avapro and trandolapril

avapro has been researched along with trandolapril in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (66.67)29.6817
2010's3 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abbenante, G; Fairlie, DP; Leung, D1
Andricopulo, AD; Moda, TL; Montanari, CA1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Barletta, G; Foschi, M; Franchi, F; Lazzeri, C; Tosti-Guerra, C1
Bernadet-Monrozies, P; Durand, D; Kamar, N; Rostaing, L1
Angermann, CE; Bauersachs, J; Behr, TM; Ertl, G; Fraccarollo, D; Frantz, S; Jung, P; Wagner, H1
Bauersachs, J; Ertl, G; Fraccarollo, D; Schäfer, A; Schmidt, I; Tas, P1

Reviews

3 review(s) available for avapro and trandolapril

ArticleYear
Protease inhibitors: current status and future prospects.
    Journal of medicinal chemistry, 2000, Feb-10, Volume: 43, Issue:3

    Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors

2000
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
[The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Presse medicale (Paris, France : 1983), 2002, Nov-09, Volume: 31, Issue:36

    Topics: Amlodipine; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Clinical Trials as Topic; Cohort Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Endothelins; Hemodynamics; Humans; Hypertension; Indoles; Irbesartan; Kidney; Kidney Failure, Chronic; Proteinuria; Randomized Controlled Trials as Topic; Receptors, Angiotensin; Renin-Angiotensin System; Tetrazoles; Verapamil

2002

Trials

1 trial(s) available for avapro and trandolapril

ArticleYear
Cardiac autonomic tone during trandolapril-irbesartan low-dose combined therapy in hypertension: a pilot project.
    Journal of human hypertension, 2002, Volume: 16, Issue:8

    Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Autonomic Nervous System; Biphenyl Compounds; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypertension; Indoles; Irbesartan; Male; Middle Aged; Pilot Projects; Tetrazoles

2002

Other Studies

5 other study(ies) available for avapro and trandolapril

ArticleYear
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Sustained activation of nuclear factor kappa B and activator protein 1 in chronic heart failure.
    Cardiovascular research, 2003, Volume: 57, Issue:3

    Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blotting, Western; Enzyme-Linked Immunosorbent Assay; Heart Failure; Humans; Indoles; Interleukin-1; Irbesartan; Male; Myocardial Infarction; NF-kappa B; Rats; Rats, Wistar; Tetrazoles; Transcription Factor AP-1; Tumor Necrosis Factor-alpha

2003
Endothelial dysfunction in congestive heart failure: ACE inhibition vs. angiotensin II antagonism.
    European journal of heart failure, 2004, Mar-01, Volume: 6, Issue:2

    Topics: Analysis of Variance; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Biphenyl Compounds; Endothelium, Vascular; Heart Failure; Indoles; Irbesartan; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Random Allocation; Rats; Rats, Wistar; Superoxides; Tetrazoles; Treatment Outcome; Vasodilation

2004
chemdatabank.com